Pilot Therapeutics
This article was originally published in The Tan Sheet
Executive Summary
Company acquires majority ownership of New York-based food distributor Interallied Group Sept. 5; will change name traded on NASDAQ OTC bulletin board to Pilot Therapeutics. Pilot plans to launch medical food Airozin - a leukotriene antagonist asthma product to be manufactured at DPT Labs in San Antonio - in first half of 2002. Radio and print ads will break approximately three months before launch, with professional campaign targeting asthma doctors and general campaign reaching the public. Saratoga Springs, N.Y.-based advertising firm Palio Communications will oversee the promotional campaign
You may also be interested in...
Pilot’s Airozin Medical Food For Asthma To Launch By Year End
Pilot Therapeutics plans to introduce its asthma maintenance therapy, Airozin, by the end of 2002 after a six-month delay, the company said
Pilot’s Airozin Medical Food For Asthma To Launch By Year End
Pilot Therapeutics plans to introduce its asthma maintenance therapy, Airozin, by the end of 2002 after a six-month delay, the company said
Pilot’s Airozin Medical Food For Asthma To Launch By Year End
Pilot Therapeutics plans to introduce its asthma maintenance therapy, Airozin, by the end of 2002 after a six-month delay, the company said